Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Presentations demonstrate therapeutic potential of Turnstone’s selected tumor-infiltrating lymphocyte therapy in a broad range of…